Chemical Compound

dibekacin

CAS Registry Number 34493-98-6

Back to search Request a Quote

Primary Record

dibekacin

In stock: 6,148 g
Purity: 98.1 %
CAS: 34493-98-6

Compound Identifiers & Properties

CAS: 34493-98-6
PubChem CID: 470999
SMILES: C1C[C@H]([C@H](O[C@@H]1CN)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N)N)N
Canonical SMILES: NC[C@@H]1CC[C@@H](N)[C@@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)O1

Names & Synonyms

dibekacin
Panamicin
Debecacin
Dibekacina
Dibekacine
Dideoxykanamycin B
Dibekacinum
Icacine
Kappati
Orbicin
3',4'-Dideoxykanamycin B
Dibekacin (INN)
Dibekacin [INN:BAN]
34493-98-6
Dibekacine [INN-French]
Dibekacinum [INN-Latin]
Spectrum_001398
Dibekacina [INN-Spanish]
Dibekacin [BAN:INN]
DIBEKACIN [INN]
DIBEKACIN [JAN]
DIBEKACIN [MI]
AC1LAM6L
RefChem:132783
Spectrum2_001528
Spectrum3_000960
Spectrum4_001074
Spectrum5_001613
DTXSID2022915
UNII-45ZFO9E525
AC1Q4UA9
DIBEKACIN [WHO-DD]
3',4' Dideoxykanamycin B
DTXCID302915
45ZFO9E525
SCHEMBL49816
KBioGR_001428
KBioSS_001878
B, 3',4'-Dideoxykanamycin
CHEBI:37945
SPBio_001316
Dideoxykanamycin B Discontinued
JJCQSGDBDPYCEO-XVZSLQNASA-N
CHEMBL560976
orb1703508
EINECS 252-064-6
GTPL12134
KBio2_001878
KBio2_004446
KBio2_007014
KBio3_002060
BRN 1441606
J01GB09
C18H39N5O12S
3 ,4 -Dideoxykanamycin B
C18H37N5O8
HY-B1129
ZINC8214383
Tox21_111496
AC-315
AR-1K9241
BBF-01838
CID470999
EBC-27128
AKOS025402025
C18-H37-N5-O8
CCG-213771
CS-4725
DB13270
NCGC00095276-01
NCGC00389765-01
BC226561
J94.714H
CAS-34493-98-6
NS00011541
D07811
AB01563356_01
EN300-20000885
(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol
Q3706873
BRD-K48427910-001-01-1
(2R,3R,4S,5S,6R)-4-AMINO-2-[(1S,2S,3R,4S,6R)-4,6-DIAMINO-3-[(2R,3R,6S)-3-AMINO-6-(AMINOMETHYL)OXAN-2-YL]OXY-2-HYDROXY-CYCLOHEXYL]OXY-6-(HYDROXYMETHYL)OXANE-3,5-DIOL
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1-6))-2-deoxy-L-streptamine
(1R,2S,3S,4R,6S)-4,6-diamino-3-(3-amino-3-deoxy-alpha-D-glucopyranosyloxy)-2-hydroxycyclohexyl 2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranoside
DKB
(1R,2S,3S,4R,6S)-4,6-diamino-3-[(3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranoside
(2S,3R,4S,5S,6R)-4-amino-2-{[(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,5-diol
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl)-(1-4)-2-deoxy-
DKM
(2S,3R,4S,5S,6R)-4-amino-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2R,3R,6S)-3-amino-6-(aminomethyl)tetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol
(2S,3R,4S,5S,6R)-4-amino-2-((1S,2S,3R,4S,6R)-4,6-diamino-3-((2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl)oxy-2-hydroxycyclohexyl)oxy-6-(hydroxymethyl)oxane-3,5-diol
(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(aminomethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol
252-064-6
6-O-(3-Amino-3-deoxy-alpha-D-glucopyranosyl)-4-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl)-2-deoxy-D-streptamine
68814-14-2
84D
D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-.alpha.-D-erythro-hexopyranosyl-(1.fwdarw.4)]-2-deoxy-
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1-4))-2-deoxy-
O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-(2,6-DIAMINO-2,3,4,6-TETRADEOXY-.ALPHA.-D-ERYTHRO-HEXOPYRANOSYL-(1->6))-2-DEOXY-L-STREPTAMINE
O-3-Amino-3-deoxy-?-D-glucopyranosyl-(1?6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-?-D-erythro-hexopyranosyl-(1?4)]-2-deoxy-D-streptamine; 3',4'-Dideoxykanamycin B; DKB; Debecacin; Dibekacin;